Form 8-K - Current report:
SEC Accession No. 0001683168-26-004116
Filing Date
2026-05-19
Accepted
2026-05-19 16:05:46
Documents
19
Period of Report
2026-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 34268
2 PLACEMENT AGENT AGREEMENT sunshine_ex1001.htm EX-10.1 195185
3 FORM OF PRE-FUNDED WARRANT sunshine_ex1002.htm EX-10.2 121875
4 FORM OF SERIES C WARRANT sunshine_ex1003.htm EX-10.3 138330
5 PRESS RELEASE, DATED MAY 18, 2026 sunshine_ex9901.htm EX-99.1 9942
6 PRESS RELEASE DATED MAY 19, 2026 sunshine_ex9902.htm EX-99.2 12391
11 GRAPHIC image_001.jpg GRAPHIC 8780
12 GRAPHIC image_002.jpg GRAPHIC 2690
  Complete submission text file 0001683168-26-004116.txt   854106

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20260518.xsd EX-101.SCH 3552
8 XBRL DEFINITION FILE sbfm-20260518_def.xml EX-101.DEF 26584
9 XBRL LABEL FILE sbfm-20260518_lab.xml EX-101.LAB 36549
10 XBRL PRESENTATION FILE sbfm-20260518_pre.xml EX-101.PRE 25208
22 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5049
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 26998620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)